Drug
Nitisinone
Nitisinone: highest development phase Phase 3, developed by Swedish Orphan Biovitrum. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nitisinone NCT02323529 | Phase 3 | Hereditary Tyrosinemia, Type I |
Latest
No recent events.
Follow Nitisinone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.